Your browser doesn't support javascript.
loading
Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities.
Qiu, Jingying; Zou, Yueting; Li, Shuqiong; Yang, Lihua; Qiu, Zibin; Kong, Fanyun; Gu, Xiaoke.
Affiliation
  • Qiu J; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China; Department of Pharmaceutical Analysis, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
  • Zou Y; Department of Pharmaceutical Analysis, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
  • Li S; Department of Pharmaceutical Analysis, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
  • Yang L; Department of Pharmaceutical Analysis, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
  • Qiu Z; College of Pharmacy, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.
  • Kong F; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China. Electronic address: kong.fanyun@163.com.
  • Gu X; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China. Electronic address: gu_xk@xzhmu.edu.cn.
Eur J Med Chem ; 244: 114833, 2022 Dec 15.
Article in En | MEDLINE | ID: mdl-36228413

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Hepatitis B Limits: Humans Language: En Journal: Eur J Med Chem Year: 2022 Document type: Article Country of publication: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Hepatitis B Limits: Humans Language: En Journal: Eur J Med Chem Year: 2022 Document type: Article Country of publication: France